India Pharmaceutical Market Report by Type (Pharmaceutical Drugs, Biologics), Nature (Organic, Conventional), and Region 2024-2032

India Pharmaceutical Market Report by Type (Pharmaceutical Drugs, Biologics), Nature (Organic, Conventional), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A6153
Buy Now

Market Overview:

The India pharmaceutical market size reached US$ 54.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 163.1 Billion by 2032, exhibiting a growth rate (CAGR) of 12.3% during 2024-2032. The increasing burden of diseases and healthcare needs, favorable government initiatives promoting the development of healthcare infrastructure, and rising health consciousness among the masses are among the key factors driving the market growth.

Report Attribute 
Key Statistics
Base Year
Forecast Years
Historical Years
Market Size in 2023
US$ 54.6 Billion
Market Forecast in 2032
US$ 163.1 Billion
Market Growth Rate 2024-2032 12.3%

Pharmaceuticals are a diverse range of medicinal products used for the diagnosis, treatment, and prevention of diseases in humans and animals. These products include prescription drugs, over-the-counter medications, vaccines, biologics, and various medical devices. Pharmaceutical research involves extensive testing and clinical trials to ensure safety, efficacy, and regulatory approval before products reach the market. The pharmaceutical industry plays a crucial role in healthcare by producing and distributing essential medicines that address numerous health conditions, improve the quality of life of patients, and contribute to medical advancements.

The country’s large population and the increasing healthcare awareness and access have contributed to the rising pharmaceuticals uptake in India. Moreover, the growing burden of various diseases, including chronic illnesses and communicable diseases, has augmented the demand for medications, driving market expansion. Apart from this, several favorable government initiatives promoting healthcare infrastructure, affordability, and accessibility have catalyzed the market growth. Besides this, the heightening popularity of medical tourism in India has fueled the demand for pharmaceuticals, as the country offers cost-effective treatment options. Additionally, the emerging reputation of India as a global hub for generic drug manufacturing and export is propelling the market growth, with affordability and availability attracting international buyers. Furthermore, rising investments in research and development (R&D) by both domestic and multinational pharmaceutical companies that fosters the development of new drug discoveries and treatments is contributing to the market growth.

India Pharmaceutical Market Trends/Drivers:

Growing Healthcare Awareness and Access

The Indian pharmaceutical market is propelled by the increasing healthcare awareness and expanding access to medical services across the country. As healthcare data becomes more easily accessible through various channels, individuals are becoming more proactive in seeking medical attention and preventive measures. This heightened awareness among the masses leads to higher demand for pharmaceutical products to address a wide range of health conditions. Moreover, the growing prevalence of non-communicable diseases, lifestyle disorders, and chronic illnesses further amplifies the need for pharmaceutical interventions. As healthcare infrastructure improves, especially in rural areas across the country, more people are gaining access to medical facilities, resulting in a larger customer base for pharmaceutical products. This factor underscores the evolving health consciousness of the Indian population, transforming the pharmaceutical market into a crucial player catering to diverse healthcare needs.

Rise in Government Initiatives and Support

The Indian market for pharmaceuticals benefits significantly from government-driven initiatives and support. Various policies aimed at promoting healthcare affordability, expanding medical infrastructure, and enhancing regulatory frameworks create a favorable environment for the growth of pharmaceutical companies in the country. Initiatives such as the 'Make in India' campaign encourage domestic production of pharmaceuticals, reducing dependency on imports. Additionally, the implementation of price controls on essential medicines ensures that pharmaceuticals remain readily accessible to a broader segment of the population. Government support also extends to research and development (R&D) incentives, which incentivize pharmaceutical companies to invest in innovations and new drug discoveries. These strategic measures drive business growth and contribute to the overall improvement of healthcare quality and accessibility in India, fostering a symbiotic relationship between the government and the pharmaceutical industry.




Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

India Pharmaceutical Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the India pharmaceutical market report, along with forecasts at the country level from 2024-2032. Our report has categorized the market based on type and nature.

Breakup by Type:




Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Pharmaceutical Drugs
    • Cardiovascular Drugs
    • Dermatology Drugs
    • Gastrointestinal Drugs
    • Genito-Urinary Drugs
    • Hematology Drugs
    • Anti-Infective Drugs
    • Metabolic Disorder Drugs
    • Musculoskeletal Disorder Drugs
    • Central Nervous System Drugs
    • Oncology Drugs
    • Ophthalmology Drugs
    • Respiratory Diseases Drugs
  • Biologics
    • Monoclonal Antibodies (MAbS)
    • Therapeutic Proteins
    • Vaccines

Pharmaceutical drugs represent the most popular type

The report has provided a detailed breakup and analysis of the market based on the product. This includes pharmaceutical drugs (cardiovascular, dermatology, gastrointestinal, genito-urinary, hematology, anti-infective, metabolic disorder, musculoskeletal disorder, central nervous system, oncology, ophthalmology, and respiratory diseases drugs) and biologics (monoclonal antibodies (MAbS), therapeutic proteins, and vaccines). According to the report, pharmaceutical drugs represented the largest segment.

The extensive range of pharmaceutical drugs produced in India caters to both domestic and international demands, positioning the country as a major global supplier. With a vast pool of skilled professionals and state-of-the-art manufacturing facilities, India produces a diverse portfolio of pharmaceutical products that address various medical conditions. This broad spectrum of drugs, encompassing generics and innovative therapies, contributes to the industry's resilience and competitiveness. India's commitment to quality assurance, regulatory compliance, and cost-effectiveness has solidified its reputation as a dependable source of medications worldwide.

Furthermore, the continuous research and development (R&D) efforts undertaken by the leading pharmaceutical companies has propelled the market growth, fostering advancements in medical treatments. As healthcare needs continue to evolve and expand, pharmaceutical drugs will remain integral to shaping the trajectory of India's pharmaceutical market, reinforcing its status as a pivotal player in the global pharmaceutical industry.

Breakup by Nature:

  • Organic
  • Conventional

Conventional accounts for the majority of the market share

A detailed breakup and analysis of the market based on the nature has also been provided in the report. This includes organic and conventional. According to the report, conventional accounted for the largest market share.

Conventional sources encompass a range of factors that contribute to the industry's growth. Traditional manufacturing practices, research methodologies, and supply chain networks form the foundation of the pharmaceutical sector. Leveraging tried-and-trusted methods, pharmaceutical companies in India produce a wide array of medications that cater to diverse medical needs. These conventional approaches ensure the availability of affordable medications and contribute to the country's position as a global pharmaceutical supplier.

Moreover, the expertise accumulated over decades of operation fosters consistency and reliability in drug manufacturing. While innovation remains essential, the steadfast reliance on conventional practices continues to underpin the industry's robustness. As India increasingly embraces modern advancements, the integration of conventional wisdom with innovative technologies is expected to further drive the market growth, maintaining the country's reputation as a prominent player in the global pharmaceutical landscape.

Breakup by Region:

  • North India
  • West and Central India
  • South India
  • East India

North India exhibits a clear dominance in the market

A detailed breakup and analysis of the market has been provided based on region. This includes North India, West and Central India, South India, and East India. According to the report, North India accounted for the largest market share.

North India with its strategic geographical location, well-established industrial infrastructure, and access to a large consumer base, exerts a substantial influence on the pharmaceutical sector. States like Himachal Pradesh, Punjab, and Haryana host numerous pharmaceutical manufacturing units, contributing substantially to the overall production output of the nation. The concentration of pharmaceutical hubs, research centers, and academic institutions in North India fosters innovation, driving advancements in drug development and medical research.

Furthermore, the region's proximity to major transportation and distribution networks facilitates the smooth flow of pharmaceutical products across the country. The strong government support and favorable policies aimed at promoting pharmaceutical investment further enhance North India's role as a leading player in shaping the growth trajectory of India's pharmaceutical industry. This influence is set to persist as the region continues to attract investment, foster innovation, and contribute to the nation's healthcare landscape.

Competitive Landscape:

The market is experiencing steady growth as numerous key players have recently introduced a wave of innovative strategies. Collaborations with research institutions and startups to explore cutting-edge therapies like gene therapies and precision medicine have gained prominence, showcasing a forward-looking approach. Moreover, there is an increasing focus on biosimilars and complex generic drugs, enabling cost-effective alternatives to expensive treatments. Additionally, advancements in personalized medicine approaches are gaining momentum, tailoring treatments based on genetic profiles. These innovations collectively represent the industry's dedication to addressing evolving healthcare needs and fostering advancements in medical science within the Indian pharmaceutical domain.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players included:

  • Abbott India Ltd (Abbott Laboratories)
  • Aurobindo Pharma Limited
  • Biocon Limited
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.
  • Divi's Laboratories Limited
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline Pharmaceuticals Limited (GSK plc)
  • Lupin Limited
  • Mankind Pharma
  • Merck Life Science Private Limited (Merck KGaA)
  • Novartis India Limited (Novartis AG)
  • Pfizer Healthcare India Pvt. Ltd. (Pfizer Inc.)
  • Procter & Gamble Health Limited (The Procter & Gamble Company)
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd. (Torrent Group)

India Pharmaceutical Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Type
  • Nature
  • Region
Types Covered
  • Pharmaceutical Drugs: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs
  • Biologics: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
Natures Covered Organic, Conventional
Regions Covered North India, West and Central India, South India, East India
Companies Covered Abbott India Ltd (Abbott Laboratories), Aurobindo Pharma Limited, Biocon Limited, Cadila Pharmaceuticals Ltd., Cipla Ltd., Divi's Laboratories Limited, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline Pharmaceuticals Limited (GSK plc), Lupin Limited, Mankind Pharma, Merck Life Science Private Limited (Merck KGaA), Novartis India Limited (Novartis AG), Pfizer Healthcare India Pvt. Ltd. (Pfizer Inc.), Procter & Gamble Health Limited (The Procter & Gamble Company), Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd. (Torrent Group) etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India pharmaceutical market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the India pharmaceutical market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India pharmaceutical industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Key Questions Answered in This Report

We expect the India pharmaceutical market to exhibit a CAGR of 12.3% during 2024-2032.

The rising demand for pain management and acute therapies, such as gastro and respiratory, along with the growing adoption of intelligent automation across the pharmaceuticals industry to diagnose and manage diseases, is primarily driving the India pharmaceutical market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing utilization of pharmaceuticals to provide adequate medicines for combating the risk of the coronavirus infection across the nation.

Based on the type, the India pharmaceutical market has been segregated into pharmaceutical drugs and biologics, where pharmaceutical drugs currently hold the majority of the total market share.

Based on the nature, the India pharmaceutical market can be bifurcated into organic and conventional. Currently, conventional nature exhibits a clear dominance in the market.

On a regional level, the market has been classified into North India, West and Central India, South India, and East India, where North India currently dominates the India pharmaceutical market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
India Pharmaceutical Market Report by Type (Pharmaceutical Drugs, Biologics), Nature (Organic, Conventional), and Region 2024-2032
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More